Revenue Growth
In the third quarter of 2024, Inogen achieved $89 million in total revenue, reflecting a 6% year-over-year growth. The business-to-business channels drove over 20% year-over-year revenue growth for the second consecutive quarter.
Positive Cash Flow
Inogen generated $3 million of positive cash flow in the third quarter, marking the second consecutive quarter of positive cash flow.
New Product Launch
The company announced the launch of the Rove 4, a portable oxygen concentrator (POC) with new features, including up to 840 milliliters of medical-grade oxygen per minute and up to 5 hours and 45 minutes of battery life.
Business-to-Business Revenue Increase
Domestic business-to-business revenue increased 35.1% to $23.4 million, and international business-to-business revenue increased 26.2% to $32.3 million.
Gross Margin Improvement
Total gross margin was 46.5%, increasing 630 basis points from the same period in the prior year.